UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025
Cash flows from operating activities
Net loss for the period	$ (35,899,646)	$ (27,259,804)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	2,136,908	1,082,482
Non-cash interest expense	847,893	89,680
Change in operating lease right-of-use assets	81,493	72,322
Loss on SEPA settlements	127,083	157,721
Change in fair value of debentures	0	583,823
Loss on extinguishment of debentures	0	25,000
IPR&D - Teverelix	0	8,717,475
Issuance cost related to SEPA	0	300,000
Cost to issue debentures and secured promissory notes	0	111,725
Issuance of common shares in connection with non-cash compensation for services rendered	466,390	0
Issuance of restricted securities in lieu of cash bonuses	1,454,264	0
Foreign exchange gain/loss	0	8,816
Changes in operating assets and liabilities:
Prepaid expenses	(257,533)	317,522
Accounts payable	(1,411,105)	(380,033)
Accrued expenses and other current liabilities	49,625	111,167
Interest payable on secured promissory notes	573,596	0
Operating lease liability	(109,009)	(106,171)
Related party payable	46,173	621
Net cash used in operating activities	(31,893,868)	(16,167,654)
Cash flows from financing activities
Net proceeds from issuance of common shares and warrants	0	9,790,015
Proceeds from issuance of shares under SEPA	0	5,097,005
Proceeds from issuance of debentures and secured promissory notes	22,000,000	11,866,293
Proceeds from issuance of common shares under ATM, net of issuance costs	17,154,819	0
Proceeds from exercise of warrants	0	4,729,398
Proceeds from exercise of stock options	0	162,400
Cost to issue debentures and secured promissory notes	(615,000)	(136,726)
Repayment of debentures and secured promissory notes	(6,397,262)	(5,637,709)
Proceeds from issuance of common shares under SEPA	4,102,740	0
Issuance costs for common shares	0	(584,361)
Net cash provided by financing activities	36,245,297	25,286,315
Cash flows from investing activities
Net cash paid for Antev asset acquisition including transaction costs	0	(4,619,152)
Net cash used in investing activities	0	(4,619,152)
Foreign currency effect on cash and cash equivalents	38,183	(1,741)
Net increase in cash and cash equivalents and restricted cash during the period	4,389,612	4,497,768
Cash and cash equivalents and restricted cash, beginning of the period	8,705,218	4,164,323
Cash and cash equivalents and restricted cash, end of the period	13,094,830	8,662,091
Supplemental information
Cash paid for interest	330,626	0
Supplemental disclosure of non-cash investing and financing activities
Deemed dividend on warrant inducement	0	4,954,518
Shares issued for acquisition of Antev	0	2,129,410
Shares to be issued for acquisition of Antev	0	313,934
Deferred issuance costs on issued shares related to SEPA agreement	0	300,000
Issuance costs included in accounts payable	$ 0	$ 95,360